Tuesday 31 July 2012

FDA rejects expanded use of Regeneron drug for gout



(Reuters) - Regeneron Pharmaceuticals Inc said U.S. regulators have denied approval for it to expand use of its Arcalyst drug to prevent gout flares, asking that the company provide more clinical data.

via Reuters: Health News Read More Here..

No comments:

Post a Comment